2022-11-03T13:55:07-04:00 2021-12-31 591978917 PRIDA GUIDA & PEREZ PA 1106 N FRANKLIN ST TAMPA FL 336023813 990 2021-01-01 593187624 JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC JAEB 8139758690 15310 AMBERLY DRIVE SUITE 350 TAMPA FL 33647 ADAM GLASSMAN EXEC DIRECTOR 8139758690 2022-10-19 true ADAM GLASSMAN XXX-XX-XXXX DANIEL HEVIA P01297993 8132266091 2022-10-19 2021 2022-09-23 18:48:47Z ROY W BECK MD PHD 15310 AMBERLY DRIVE SUITE 350 TAMPA FL 33647 30945662 false X WWW.JAEB.ORG X 1998 FL DEVELOP AND CONDUCT CLINICAL TRIALS AND EPIDEMIOLOGIC RESEACH 5 4 154 0 36874622 30943273 0 59752 2389 0 36934374 30945662 8252140 2005000 0 14658133 15409998 0 0 20982535 16325423 43892808 33740421 -6958434 -2794759 11858596 6686378 14068592 11691133 -2209996 -5004755 X DESIGN AND CONDUCT CLINICAL TRIALS AND EPIDEMIOLOGIC RESEARCH false false 27578201 2005000 DURING 2021, JCHR HAD 47 ACTIVE CLINICAL STUDIES. IN ADDITION TO INDUSTRY COLLABORATIONS, JCHR STUDIES WERE FUNDED BY THE NATIONAL INSTITUTES OF HEALTH (24), HELMSLEY CHARITABLE TRUST (6), JUVENILE DIABETES RESEARCH ROUNDATION (8), FOUNDATION FIGHTING BLINDNESS (3), AND THE FOOD AND DRUG ADMINISTRATION (1). A PLANNING GRANT WAS ALSO PROVIDED BY THE CYSTIC FIBROSIS FOUNDATION FOR AN OBSERVATION STUDY INVOLVING INDIVIDUALS WITH CYSTIC FIBROSIS TO BEGIN IN 2022. AMONG 2,850 ENTITIES RECEIVING NIH FUNDING IN 2021, JCHR RANKS IN THE TOP 8%. ADDITIONALLY, JCHR'S GRANT FUNDING FROM THE NATIONAL EYE INSTITUTE DURING 2021 PLACED IT FOURTH NATIONALLY AMONG ALL UNIVERSITIES. DURING 2021, JCHR PROJECTS HAD 73 MANUSCRIPTS PUBLISHED OR ACCEPTED FOR PUBLICATION AND 51 PRESENTATIONS MADE AT NATIONAL AND INTERNATIONAL MEETINGS. IN ADDITION TO CONVENTIONAL CLINIC-BASED CLINICAL TRIALS, JCHR CONDUCTED SEVRAL "DRECT-TO-PATIENT" STUDIES IN WHICH JCHR STAFF HAD DIRECT CONTACT WITH STUDY PARTICIPANTS WHO PROVIDED DATA VIA THE INTERNET AND FROM DEVICES. EYE DISEASE PROJECTS CONTINUE IN THREE NETWORKS: DRCR RETINA NETWORK WHICH STUDIES DIABETIC REINOPATHY AND OTHER RETINAL DISEASES; PEDIATRIC EYE DISEASE INVSTIGATOR NETWORK (PEDIG) WHICH STUDIES A RANGE OF EYE DISEASES IN CHILDREN; AND FOUNDATION FIGHTING BLINDNESS CONSORTIUM, WHICH RESEARCHES RETINITIS PIGMENTOSA AND OTHER RARE RETINAL DISEASES. ADDITIONALLY, TWO STUDIES EVALUATING CORNEA TRANSPLANT APPROACHES ARE UNDER WAY. JCHR'S INVOLVEMENT IN DIABETES STUDIES CONTINUES TO EXPAND, WITH ITS REPUTATION AS THE PREMIERE COORDINATING CENTER WORLDWIDE FOR DIABETES DEVICE STUDIES 27578201 true true false false false false false false false false true false false true true false false true false false false false false false false false false true false true false false false false false false false false false false false false false true false false false true 81 0 true 154 true false false false false false false false false false false false false false false X 5 4 false false false false false false false true true false false true true true true true true true true false X ROY W BECK MD PHD 8139758690 15310 AMBERLY DRIVE SUITE 350 TAMPA FL 33647 ROY W BECK MD PHD PRESIDENT 60.00 1.00 X X 524948 0 21750 ADAM GLASSMAN EXEC DIRECTO 40.00 0.00 X 257850 0 10683 CRAIG KOLLMAN DIR, BIOSTAT 40.00 0.00 X 250489 0 10378 B MICHELLE MELIA SR BIOSTATIS 40.00 0.00 X 216700 0 8978 JAMES PYNER CHF INFORMAT 40.00 0.00 X 183867 0 7618 RAYMOND KRAKER EPIDEMIOLOGI 40.00 0.00 X 183867 0 7618 ALLISON AYALA BIOSTATISTIC 40.00 0.00 X 181030 0 7500 PETER CALHOUN BIOSTATISTIC 40.00 0.00 X 179947 0 7456 ROBIN GAL EPIDEMIOLOGI 40.00 0.00 X 168957 0 7000 KATRINA RUEDY EPIDEMIOLOGI 40.00 0.00 X 156884 0 6500 JAMES WILLIS FINANCE & OP 40.00 0.00 X 88852 0 3681 RAMESH AYYALA DIRECTOR 1.00 1.00 X 0 0 0 ANNE LINDBLAD DIRECTOR 1.00 1.00 X 0 0 0 SHAN SHIKARPURI DIRECTOR 1.00 1.00 X 0 0 0 LESLEY S ZAJAC DIRECTOR 1.00 1.00 X 0 0 0 2393391 99162 10 false true false AMERICAN EXPRESS PO BOX 360001 FT LAUDERDALE FL 33336 CREDIT CARD PRO 1268471 PLTP INVESTORS LLC 135 W CENTRAL BOULEVARD SUITE 900 ORLANDO FL 32801 RENT 1058434 CECEILA HEALTH 1601 THIRD AVENUE STE 11-J NEW YORK NY 10128 SUBCONTRACTOR 820220 HEALTH PARTNERS INSTITIUTE 8170 33RD AVENUE SOUTH MINNEAPOLIS MN 55425 SUBCONTACTOR 720176 DEXCOM 6340 SQUENCE DRIVE SAN DIEGO CA 92121 DEVICES 705213 5 14676230 16267043 30943273 2389 2389 30945662 2389 2005000 2005000 1381409 1022256 359153 10026931 7419175 2607756 1552696 1148995 403701 1526276 1129444 396832 922686 682788 239898 22017 22017 51906 51906 339536 295101 44435 422599 355730 66869 548803 51962 496841 987533 987533 22177 15478 6699 2821 2821 242600 242600 145016 42649 102367 SUBCONTRACTORS 11463137 11463137 RESEARCH EXPENSES 1837670 1836263 1407 MISC. EXPENSES 239608 110223 129385 33740421 27578201 6162220 0 911282 2737260 9222805 1111169 2281341 131 1670 2089073 1756368 575305 332705 36365 1334941 11858596 6686378 1909018 1263471 12159574 8585291 1842371 14068592 11691133 X -2209996 -5004755 -2209996 -5004755 11858596 6686378 -2794759 X false true X true true true X 32488623 34277822 31955018 36874622 30943273 166539358 32488623 34277822 31955018 36874622 30943273 166539358 27899380 138639978 13400 387 219897 59752 2389 295825 166835183 0.83100 0.76930 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 520608 474513 46095 1278590 1008743 269847 289875 273112 16763 332705 OPERATING LEASE RIGHT-OF-USE ASSETS 1298617 SECURITY DEPOSITS 36324 1334941 OPERATING LEASE LIABILITES 1317437 ACCRUED EXPENSES 524934 1842371 true JAEB CENTER RESEARCH TRUST INC 15310 AMBERLY DRIVE TAMPA FL 33647 270717710 501C3 2000000 SUPPORT 1 SCHEDULE I, PAGE 1, PART I, LINE 2 THE ORGANIZATION GRANTS FUNDS TO OTHER EXEMPT ORGANIZATIONS WHICH SUPPORT ITS MISSION. X X false false false false false false false false false ROY W BECK MD PHD PRESIDENT 524948 21750 546698 ADAM GLASSMAN EXEC DIRECTOR 257850 10683 268533 CRAIG KOLLMAN DIR, BIOSTATISTICS 250489 10378 260867 B MICHELLE MELIA SR BIOSTATISTICIAN 216700 8978 225678 JAMES PYNER CHF INFORMATION OFCR 183867 7618 191485 RAYMOND KRAKER EPIDEMIOLOGIST IV 183867 7618 191485 ALLISON AYALA BIOSTATISTICIAN IV 181030 7500 188530 PETER CALHOUN BIOSTATISTICAN IV 179947 7456 187403 ROBIN GAL EPIDEMIOLOGIST IV 168957 7000 175957 KATRINA RUEDY EPIDEMIOLOGIST IV 156884 6500 163384 FORM 990, PAGE 2, PART III, LINE 4A DURING 2021, JCHR HAD 47 ACTIVE CLINICAL STUDIES. IN ADDITION TO INDUSTRY COLLABORATIONS, JCHR STUDIES WERE FUNDED BY THE NATIONAL INSTITUTES OF HEALTH (24), HELMSLEY CHARITABLE TRUST (6), JUVENILE DIABETES RESEARCH ROUNDATION (8), FOUNDATION FIGHTING BLINDNESS (3), AND THE FOOD AND DRUG ADMINISTRATION (1). A PLANNING GRANT WAS ALSO PROVIDED BY THE CYSTIC FIBROSIS FOUNDATION FOR AN OBSERVATION STUDY INVOLVING INDIVIDUALS WITH CYSTIC FIBROSIS TO BEGIN IN 2022. AMONG 2,850 ENTITIES RECEIVING NIH FUNDING IN 2021, JCHR RANKS IN THE TOP 8%. ADDITIONALLY, JCHR'S GRANT FUNDING FROM THE NATIONAL EYE INSTITUTE DURING 2021 PLACED IT FOURTH NATIONALLY AMONG ALL UNIVERSITIES. DURING 2021, JCHR PROJECTS HAD 73 MANUSCRIPTS PUBLISHED OR ACCEPTED FOR PUBLICATION AND 51 PRESENTATIONS MADE AT NATIONAL AND INTERNATIONAL MEETINGS. IN ADDITION TO CONVENTIONAL CLINIC-BASED CLINICAL TRIALS, JCHR CONDUCTED SEVRAL "DRECT-TO-PATIENT" STUDIES IN WHICH JCHR STAFF HAD DIRECT CONTACT WITH STUDY PARTICIPANTS WHO PROVIDED DATA VIA THE INTERNET AND FROM DEVICES. EYE DISEASE PROJECTS CONTINUE IN THREE NETWORKS: DRCR RETINA NETWORK WHICH STUDIES DIABETIC REINOPATHY AND OTHER RETINAL DISEASES; PEDIATRIC EYE DISEASE INVSTIGATOR NETWORK (PEDIG) WHICH STUDIES A RANGE OF EYE DISEASES IN CHILDREN; AND FOUNDATION FIGHTING BLINDNESS CONSORTIUM, WHICH RESEARCHES RETINITIS PIGMENTOSA AND OTHER RARE RETINAL DISEASES. ADDITIONALLY, TWO STUDIES EVALUATING CORNEA TRANSPLANT APPROACHES ARE UNDER WAY. JCHR'S INVOLVEMENT IN DIABETES STUDIES CONTINUES TO EXPAND, WITH ITS REPUTATION AS THE PREMIERE COORDINATING CENTER WORLDWIDE FOR DIABETES DEVICE STUDIES FORM 990, PAGE 6, PART VI, LINE 11B THE BOARD OF DIRECTORS REVIEWS AND APPROVES FORM 990 PRIOR TO THE FORM'S FILING. FORM 990, PAGE 6, PART VI, LINE 12C THE GOVERNING BODY ANNUALLY SIGNS A STATEMENT AFFIRMING RECEIPT OF THE CONFLICT OF INTEREST POLICY, THAT HE/SHE HAS READ AND UNDERSTANDS THE POLICY, AGREES TO COMPLY WITH THE POLICY AND UNDERSTANDS THE ORGANIZATION IS CHARITABLE AND IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX- EXEMPT PURPOSES. FORM 990, PAGE 6, PART VI, LINE 15A EACH YEAR THE SALARY SUBCOMMITTEE OF THE BOARD OF DIRECTORS MEETS TO DETERMINE THE SALARY FOR THE PRESIDENT, EXECUTIVE DIRECTOR,AND THE CHIEF RESEARCH COMPLIANCE OFFICER. FORM 990, PAGE 6, PART VI, LINE 15B ALL OTHER SALARIES ARE REVIEWED BY EXECUTIVE DIRECTOR IN CONJUNCTION WITH WRITTEN ANNUAL PERFORMANCE REVIEW. FORM 990, PAGE 6, PART VI, LINE 19 ANY MEMBER OF THE PUBLIC CAN COME IN AND INSPECT THE PUBLICLY AVAILABLE PORTIONS OF OUR GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS IN OUR OFFICE DURING REGULAR OFFICE HOURS. JAEB CENTER RESEARCH TRUST INC 15310 AMBERLY DRIVE SUITE 350 TAMPA FL 33647 270717710 SUPPORT FL 501C3 12B N/A false false true false false false false false false false false false false false true true false false false false JAEB CENTER RESEARCH TRUST INC B 2000000 CASH JAEB CENTER RESEARCH TRUST INC N SEE NOTE JAEB CENTER RESEARCH TRUST INC O SEE NOTE SCHEDULE R SCHEDULE R, PART V, ITEMS N AND O: THE ORGANIZATION SHARES FACILITIES, EQUIPMENT AND PAID EMPLOYEES WITH JAEB CENTER RESEARCH TRUST, INC. NEITHER ORGANIZATION ASSIGNS A VALUE TO THIS TRANSACTION.